ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,129Medicare Part D Prescriptions Filled, Including Refills

Rank: 400 out of 780

$358K Total Retail Price of All Prescriptions

Rank: 421 out of 780

310 Patients Receiving at Least One Drug in Part D
48%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

18% of this provider’s 310 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 3,996 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
AMLODIPINE BESYLATE 526 347 1 4
FOSINOPRIL SODIUM 290 197 2 112
HYDROCHLOROTHIAZIDE 280 189 3 10
TRAMADOL HCL 265 117 4 15
PRAVASTATIN SODIUM 247 166 5 9
LOSARTAN POTASSIUM 212 117 6 18
METFORMIN HCL 197 115 7 8
SIMVASTATIN 197 129 7 2
RANITIDINE HCL 187 125 9 39
HYDROCODONE-ACETAMINOPHEN 169 82 S3 10 1
GABAPENTIN 144 61 11 13
CARVEDILOL 138 70 12 14
NEXIUM 137 42 13 22
ACETAMINOPHEN-CODEINE 117 70 S3 14 116
CHLORTHALIDONE 115 51 15 142
LEVOTHYROXINE SODIUM 112 85 16 5
OMEPRAZOLE 110 49 17 3
METOPROLOL TARTRATE 110 71 17 19
FUROSEMIDE 107 57 19 7
POTASSIUM CHLORIDE 99 66 20 11
INSULIN SYRINGE 96 42 21 80
PROAIR HFA 91 43 22 62
LABETALOL HCL 88 55 23 159
LOSARTAN-HYDROCHLOROTHIAZIDE 87 44 24 33
CRESTOR 85 37 25 32
CYCLOBENZAPRINE HCL 82 23 R 26 42
SPIRONOLACTONE 80 25 27 53
LISINOPRIL 79 30 28 6
NOVOLIN 70-30 76 50 29 164
FLUTICASONE PROPIONATE 75 27 30 41
GLIPIZIDE 74 61 31 74
AMITRIPTYLINE HCL 73 25 R 32 48
METHOCARBAMOL 68 24 R 33 84
TRAZODONE HCL 67 47 34 35
GLYBURIDE 67 39 R 34 101
ALLOPURINOL 65 30 36 29
FELODIPINE ER 64 55 37 126
KLOR-CON 10 58 39 38 90
NIFEDIPINE ER 58 58 38 115
METOPROLOL SUCCINATE 57 51 40 20
LISINOPRIL-HYDROCHLOROTHIAZIDE 56 19 41 26
VERAPAMIL ER 54 20 42 78
HYDRALAZINE HCL 54 43 42 54
MELOXICAM 53 0 44 16
CLONIDINE HCL 50 44 45 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 26, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.